The main message is that GLP-1 therapy behaves more like a long-term risk-reduction treatment than a short-term fix, said Robert Glatter, MD, attending physician in the Department of Emergency Medicine at Lenox Hill Hospital in New York City, and assistant professor of Emergency Medicine at Zucker School of Medicine at Hofstra/ Northwell, in a previous interview
Many GLP-1 boosting supplements contain prebiotic fiber that promotes SCFA production (like butyrate), which can stimulate GLP-1 release in the colon
Per HumeCare's Medications Safety Information, the most commonly reported side effects are typically mild and tend to resolve after the first several weeks of treatment: nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, abdominal distension, reflux, headache, fatigue, and dizziness
An individuals lifestyle, diet, genetics, and how well they respond to the medication also play a role